Photo of Charles L. Bennett

Charles L. Bennett

Lecturer - VA, DOM Hematology/Oncology


Building & Room:



833 S. Wood Street, Chicago, IL, 60612

Office Phone:

(312) 996-6300

Selected Publications

  • Hynes DM, Tarlov ER, Durazo-Arvizu RA, Perrin RB, Zhang QL, Weichle T, Ferreira M, Lee T, Benson A, Bhoopalam N, Bennett C. Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(15):2571-6. doi:10.1200/JCO.2009.23.5200.
  • McKoy JM, Lyons EA, Obadina ES, Carson KE, Pickard AT, Schellhammer PL, McLeod D, Boyd C, McWilliams N, Sartor O, Schumock G, McCaffery K, Bennett C. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(34):8894-905. doi:10.1200/JCO.2005.01.4605.
  • Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg JT, Schumock GR, Carson KR, Ferreira MC, Dolan NL, Bennett C. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(34):8877-83. doi:10.1200/JCO.2005.02.6278.
  • Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven AJ, Sharifi RT, Wu ZL, Knight S, McWilliams N, Schumock G, Bennett C. Opportunities for disease state management in prostate cancer.. Disease management : DM. 2005;8(4):235-44. doi:10.1089/dis.2005.8.235.
  • Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer DP, West DS, Sartor OW, Tallman M, Raisch D. The Research on Adverse Drug Events and Reports (RADAR) project.. JAMA. 2005;293(17):2131-40. doi:10.1001/jama.293.17.2131.
  • Calhoun EA, Schumock GT, McKoy JM, Pickard SA, Fitzner KA, Heckinger EF, Powell ER, McCaffrey KL, Bennett C. Granulocyte colony–stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.. PharmacoEconomics. 2005;23(8):767-75.
  • Bennett CL, Luminari SR, Nissenson AS, Tallman MA, Klinge SM, McWilliams NA, McKoy JM, Kim BW, Lyons EM, Trifilio SM, Raisch DT, Evens AM, Kuzel T, Schumock G, Belknap S, Locatelli F, Rossert J, Casadevall N. Pure red-cell aplasia and epoetin therapy.. The New England journal of medicine. 2004;351(14):1403-8. doi:10.1056/NEJMoa040528.
  • Arozullah AM, Calhoun EA, Wolf MK, Finley DA, Fitzner KA, Heckinger ES, Gorby NT, Schumock GL, Bennett C. The financial burden of cancer: estimates from a study of insured women with breast cancer.. The journal of supportive oncology. 2004;2(3):271-8.
  • Ladewski LA, Belknap SM, Nebeker JR, Sartor OA, Lyons EC, Kuzel TS, Tallman MW, Raisch DR, Auerbach AT, Schumock GC, Kwaan HL, Bennett C. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(20):3859-66. doi:10.1200/JCO.2003.04.537.
  • Bennett CL, Schumock GT. Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?. Drugs & aging. 2003;20(7):479-83.
  • Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism.. The American journal of medicine. 2002;113(7):603-6.